HB 276 revises Maryland's Public Access Automated External Defibrillator (AED) Program to clarify requirements for entities using AEDs. It establishes a mandatory "AED Coordinator" role to maintain AED functionality and reporting, repeals outdated requirements for regional council AED committees, and exempts law enforcement agencies from needing a certificate for AEDs deployed in patrol vehicles. The bill affects businesses, organizations, and government entities that operate public AEDs, requiring them to maintain written AED plans and coordinate with emergency services. Key changes streamline oversight while ensuring AEDs remain accessible and properly maintained for public use during cardiac emergencies.
This bill modifies when health coverage starts for small business employees enrolling during special periods (like marriage, divorce, birth, or court orders). It allows SHOP Exchanges to let employees choose whether coverage begins the next month or the month after, based on when they submit their plan selection (first half of month = next month start; second half = two months later). This directly affects Maryland small businesses using SHOP Exchange plans and their employees who qualify for these special enrollment events. The change applies specifically to enrollments triggered by court orders, death, or divorce/separation. The bill takes effect October 1, 2026.
HB 277 strengthens oversight of third-party administrators (TPAs) in Maryland’s insurance industry. It expands grounds for the Insurance Commissioner to deny, suspend, or revoke a TPA’s registration - including violations of insurance laws - and increases civil penalties for violations from $1,000 per day to a maximum of $10,000 per violation. The bill also requires the Commissioner to consider factors like the seriousness of the violation, the TPA’s history, and harm to plan participants when setting penalties. This directly affects TPAs managing insurance claims and benefits, imposing stricter accountability for compliance with Maryland’s insurance regulations, effective October 1, 2026.
HB 275 requires Maryland insurance carriers to issue Medicare supplement policies without discrimination based on health status during specific enrollment periods. It directly affects Medicare beneficiaries transitioning from Maryland Medical Assistance (Medicaid), disabled individuals under 65 eligible for Medicare, and those with certain federal special enrollment rights. Key provisions include banning denials or higher premiums due to health conditions during a 63-day window after Medicaid termination or qualifying events, and mandating equal or lower-benefit policy options during birthday renewals starting in 2026. The bill ensures these groups can access coverage without health-based barriers, effective July 1, 2026.
HB 280 codifies Maryland’s health insurance requirements for mental health and substance use disorder coverage to align with federal parity laws. It requires health insurers to collect and report data on access to these services, explain differences in coverage rules, and comply with federal standards for equal treatment. The Maryland Insurance Commissioner will review insurer reports and address noncompliance. This bill directly affects health insurance companies and their policyholders seeking mental health or substance use disorder care.
HB 278, the "Longevity Ready Maryland Act," requires Maryland's Secretary of Aging to lead implementation of the Longevity Ready Maryland Plan. This plan aims to coordinate state services for older adults by evaluating their needs, assessing existing programs, and fostering cross-sector collaboration across health, housing, employment, and social services. The bill mandates annual reports to the governor and legislature on progress, updates the Commission on Aging's role, and requires a comprehensive statewide plan to be revised every four years. It directly affects older Marylanders, the Department of Aging, local area agencies on aging, and state agencies responsible for aging-related services.
HB 236 extends the required blood testing window for combat sports athletes in Maryland from 30 days to 90 days. It affects boxers, kickboxers, wrestlers, and mixed martial arts competitors seeking licenses or participating in contests. The bill mandates that applicants and licensed contestants must provide documented evidence of negative tests for HIV, hepatitis B, and hepatitis C within 90 days prior to license application or competition. This change modifies existing Maryland law (Sections 4-101 and 4-304.1 of the Business Regulation Article) to align testing timing with the State Athletic Commission's requirements. The bill takes effect October 1, 2026.
HB 7 authorizes Maryland's State Board of Examiners to issue limited licenses for music therapists who are completing full licensing requirements but lack sufficient clinical experience. This directly affects new music therapists and healthcare facilities needing to hire them under supervision while they fulfill certification steps. The bill creates a 1-year limited license (renewable once) requiring direct supervision by a fully licensed music therapist, with a 2-year deadline to obtain full licensure. It explicitly states limited licenses cannot replace services from audiologists or speech-language pathologists. The policy change streamlines entry into the profession without altering existing practice standards for music therapy.
HB 393 requires health insurers, nonprofit health plans, HMOs, and managed care organizations in Maryland to cover scalp cooling systems when they provide coverage for chemotherapy treatments for cancer. This applies directly to cancer patients undergoing chemotherapy who use scalp cooling to prevent hair loss, and to the insurers that must now include this coverage. The bill defines scalp cooling systems as medical devices designed for repeated use to preserve hair during cancer treatment. Coverage must be provided for these systems as part of chemotherapy treatment plans, effective January 1, 2027. The law amends Maryland’s Insurance Article (Section 15-864) to mandate this coverage for qualifying health plans.
SB 385 (The Vax Act) requires Maryland’s Secretary of Health to issue evidence-based recommendations for immunizations, screenings, and preventive services, aligning with guidance from major medical organizations like the CDC and U.S. Preventive Services Task Force. It expands pharmacists’ authority to administer vaccines (including those recommended by CDC or the Secretary) to patients aged 3+ after completing specific training and certification, while mandating health insurers to cover these services without cost-sharing. The bill also repeals outdated pertussis-related provisions and updates reporting requirements for pharmacists. This directly affects pharmacists, health insurers, and patients seeking preventive care, aiming to improve access to vaccinations and screenings.
